EU Panel Backs Eli Lilly’s Foundayo Weight-Loss Pill
A European Medicines Agency panel issued a positive opinion on Foundayo, also known as orforglipron, for weight management and type 2 diabetes, moving Eli Lilly closer to a European launch.
A European Medicines Agency panel issued a positive opinion on Foundayo, also known as orforglipron, for weight management and type 2 diabetes, moving Eli Lilly closer to a European launch.